Krausz Csilla, Looijenga Leendert H J
Andrology Unit, Department of Clinical Physiopathology, University of Florence, Florence, Italy.
Cell Cycle. 2008 Nov 15;7(22):3519-24. doi: 10.4161/cc.7.22.6980. Epub 2008 Nov 12.
Testicular Germ Cell Tumor (TGCT) is the most common malignant tumor in young Caucasian men with an annual increase of 3-6% in the past 50 years. Data in the literature indicate that both environmental and genetic factors acting on the primordial gonocyte/gonocyte are implicated in the etiopathogenesis of this tumour. Genetic linkage and genome-wide analyses did not reveal a major gene effect so far, implying that multiple loci must contribute to the development of TGCTs. Only one significant genetic risk factor has been reported, the so called "gr/gr" deletion of the Y chromosome which still request further confirmation by independent studies. On the other side, the analysis of somatic genetic changes through mutation and genome imbalance analyses and expression profiling has just began to unravel the complex interaction of multiple pathways involved in TGCTs. This review focuses on genetic factors (both genomic and somatic) involved in the etiology, progression and treatment sensitivity of TGCTs.
睾丸生殖细胞肿瘤(TGCT)是年轻白种男性中最常见的恶性肿瘤,在过去50年中每年以3%至6%的速度增长。文献数据表明,作用于原始生殖母细胞/生殖母细胞的环境和遗传因素均与该肿瘤的发病机制有关。迄今为止,遗传连锁和全基因组分析尚未揭示主要基因效应,这意味着多个基因座必定对TGCT的发生发展起作用。仅报道了一个显著的遗传风险因素,即所谓的Y染色体“gr/gr”缺失,但仍需独立研究进一步证实。另一方面,通过突变、基因组失衡分析和表达谱分析对体细胞遗传变化的研究才刚刚开始揭示TGCT中多个途径的复杂相互作用。本综述重点关注与TGCT的病因、进展和治疗敏感性相关的遗传因素(包括基因组和体细胞因素)。